Back to Search
Start Over
Emmaus Life Sciences' Endari receives Puerto Rico Department of Health marketing authorisation
- Source :
- M2 Pharma. February 5, 2024
- Publication Year :
- 2024
-
Abstract
- M2 PHARMA-February 5, 2024-Emmaus Life Sciences' Endari receives Puerto Rico Department of Health marketing authorisation (C)2024 M2 COMMUNICATIONS Emmaus Life Sciences, Inc. (OTCQX: EMMA), a California-based company involved in sickle [...]
- Subjects :
- Sickle cell anemia
Glutamine
Marketing
Chemistry
Endari (Medication)
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Pharma
- Publication Type :
- News
- Accession number :
- edsgcl.781452507